Shortwave Life Sciences has announced it has achieved a significant breakthrough in its ambitions to transform eating disorder care with positive pre-clinical results from its latest pharmacodynamics study, demonstrating the safety of its psilocybin-based drug combination for the treatment of anorexia nervosa. The post Shortwave Life Sciences psilocybin drug shows positive results in anorexia trial appeared first on Psychedelic Health.
